PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1388789
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1388789
High-resolution melting analysis is a potent technique in molecular biology to detect epigenetic differences, mutations, and polymorphisms in double-stranded DNA samples. Additionally, high-resolution melting analysis has various benefits over genotyping technologies including cost effectiveness, it is comparatively simple, and it is powerful and fast over genotyping technologies.
The major factors that are propelling the growth of the high-resolution melting analysis market comprise the growing prevalence of COPD, cardiovascular diseases, and chronic diseases such as cancer. The advantages associated with high-resolution melting analysis are patient compliance, cost savings on several treatments, disease diagnosis, optimization of therapies, and drug safety. Thereby, it is expected to boost the demand for DNA testing services. Additionally, additional aspects that are attributed to fuel the growth of the high-resolution melting analysis market over the forecast period are increasing awareness about the applications of high-resolution melting analysis technologies for HLA typing, DNA mapping, and mutation discovery. Moreover, it is a technology used for assessing melting curve plots of amplified genes. This specific technology is typically employed for gene mutation scanning, methylation profiling, microbial species identification, and other different diagnostics based on PCR. Thus, mutation scanning and other applications continue to gain prominence over time due to the increasing incidence of advancements in the technology of molecular biology, growing awareness about SNP typing, and genetic disorders. However, security concerns regarding data storage and several technical limitations coupled with HRM-QPCR analysis are likely to hinder the growth of the market.
High-resolution melting analysis can detect genetic differences that predict an individual's response to a specific treatment, paving the way for the development of tailored medicine.
The global high resolution melting analysis market is segmented on the basis of product, application, end-use, and region.
The market is divided into three categories based on product: software, reagents, and instruments. The reagents segment is accounted to witness the highest revenue share during the forecast period. The segment is attributed to factors such as cost-effectiveness and rising research regarding HIV, cancer, and other genetic diseases by universities and academic researchers. Moreover, the instruments segment is likely to maintain its dominance due to the rising use of personalized medicine and molecular diagnostics for the rising demand for high-resolution melting analysis equipment. The demand for effective and precise diagnostic tools is also being fueled by the rising prevalence of chronic diseases such as cardiovascular disorders, cancer, and infectious diseases.
The market is divided into two categories based on end-uses: clinical diagnostics and academic research. The academic research segment is likely to possess the largest market share. The growth of the segment is anticipated to be driven by the growing demand for efficient and simple molecular diagnostics and technological advancements from traditional genotyping utilizing labeled probes for high-resolution melt analysis techniques. Additionally, the rising demand for powerful and fast genotype analysis of larger samples for massive-scale genotyping projects is attributed to positively reinforcing the demand for the market globally.
Region-wise, the high-resolution melting analysis market can be segmented into North America, Asia Pacific, Europe, and the Rest of the World. North America is likely to perform extremely due to factors such as the prevalence of many academic universities, robust adoption of advanced technology in healthcare, strong biotech and pharmaceutical industry, numerous genetic testing centers, and high prevalence of diseases. Moreover, Asia Pacific is expected to be identified as one of the potential regions where the market is accounted to grow steadily owing to dynamics including rising prevalence of chronic diseases such as COPD, HIV, and cancer, rising cases of genetic disorders, and increasing public and private expenditure on genetic testing and molecular diagnostic.
The increased prevalence of chronic diseases, boosting demand for personalized medication, and improvements in molecular diagnostics technology are all projected to contribute to the significant rise of the high-resolution melting analysis market revenue growth globally. Rising government budget provision for research and development in the area of biotechnology, pharmaceuticals, and applied life sciences is an important factor heightening the demand for several diagnostic tools and techniques. Moreover, the high-resolution melting analysis market is oligopolistic, with few companies witnessing maximum share. Manufacturers of these devices face fierce competition and continuously focus on enhancing their customer pool through organic and inorganic growth strategies such as new product launches, mergers & acquisitions, agreements, expansions, joint ventures, and partnerships to strengthen their position in this market. For instance, in April 2021, Agilent Technologies, Inc. announced the acquisition of Resolution Bioscience, a leader in the development and commercialization of next-generation sequencing (NGS)-based precision oncology solutions.
For instance, in April 2021, Bio-Rad Laboratories, Inc. launch of the SARS-CoV-2 Variant RT-PCR Assays for study use only. The assays can identify SARS-CoV-2 variants of concern, including P.1, B.1.351, along with B.1.1.7, by distinctive particular mutations in SARS-CoV-2 using contrary transcription PCR (RT-PCR) often before next-generation sequencing system for confirmation.
The scope of this report covers the market by its major segments, which include as follows: